← Back to Patent Explorer
US4567193A Expired / Lapsed US ⏱️ 0.0 years remaining

2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and use as anti-allergics

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1983-07-22
•
Granted: 1986-01-28
•
Expires: 2003-07-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and its pharmaceutically acceptable salts are useful as antiallergic agents. The compounds are prepared by the reaction of 2-amino-N-(1H-tetrazol-5-yl)benzamide with formic acetic anhydride.

Inventors

  • 👤 Norton P. Peet
  • 👤 Shyam Sunder

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 19:11
CPC Classifications
C; C07; C07D; C07D275/00; C07D275/04; C07D275/06; C07D257/00; C07D257/02; C07D257/04; A; A61; A61P; A61P37/00; A61P37/08; C07D257/06

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 7 words
2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 7 words
2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 9 words
A compound according to claim 1 which is 2-(formylamino)-N-(1H-tetrazol-5-yl)benzamide.
Claim 4
Independent Claim 33 words
A method for inhibiting the result of antibody-antigen reactions in mammals which comprises administration to a mammal susceptible to allergic reaction of an effective amount of 2-(formylamino)-N-(1H-tetrazol-5-yl)benzamide or a pharmaceutically acceptable salt thereof.
Claim 5
Independent Claim 33 words
A method for inhibiting the result of antibody-antigen reactions in mammals which comprises administration to a mammal susceptible to allergic reaction of an effective amount of 2-(formylamino)-N-(1H-tetrazol-5-yl)benzamide or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US4146631A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-01-27 1989-07-29 1990-01-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-01-27 1993-07-29 1994-01-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-01-27 1997-07-29 1998-01-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag